Masitinib companion diagnostic - AB Science/Skuldtech
Latest Information Update: 07 Nov 2012
At a glance
- Originator AB Science; Skuldtech
- Class Diagnostic agents
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Pancreatic cancer
Most Recent Events
- 03 Nov 2012 Clinical trials in Pancreatic cancer (diagnosis) in USA (unspecified route)